5.4.2 Adverse Reactions and Reporting Issues

Introduction

The testimonies from the recent NCI hearings in Regina brought to light significant concerns regarding adverse reactions to the COVID-19 vaccines and issues with the reporting systems. These issues are critical because they highlight potential gaps in our understanding of vaccine safety and the effectiveness of the systems in place to monitor and address these concerns. The November 28, 2023 NCI Report corroborates these concerns with substantial evidence.

Testimonies on Adverse Reactions and Reporting Issues

Dr. Jessica Rose

• Findings: Dr. Rose’s analysis of the VAERS data indicated a significant underreporting of adverse events. She stated that VAERS, being a voluntary system, underreports actual adverse events by a factor of 31 times. This means that the actual number of adverse events would be much higher than reported.

• Comparative Data: According to Dr. Rose, adverse events related to the COVID-19 vaccines were approximately 116 times higher than those related to influenza vaccines. Specifically, the COVID-19 vaccine resulted in 25 times more adverse effects per million injections and about 70 times more deaths per million injections when compared to influenza vaccines.

• Cancer Rates: Dr. Rose emphasized an increase in cancer incidence potentially related to DNA and RNA contamination in the vaccines during the manufacturing process. This contamination has been confirmed by several independent laboratories. The inclusion of SV40, a known cancer-causing agent, was particularly concerning.

Dr. Pierre Kory

• Findings: Dr. Kory’s testimony highlighted the resistance to early treatment options like ivermectin and how the focus was shifted toward promoting vaccines despite emerging safety signals. He pointed out the significant censorship and discrediting of alternative treatments and early adverse event reporting.

Dr. Robert Chandler

• Adverse Reactions in Women: Dr. Chandler presented data indicating that 72 per cent of adverse reactions were found in women, with 16 per cent involving the reproductive system. This raises significant concerns about the impact of the vaccines on women’s health, particularly regarding fertility and pregnancy outcomes.

• Live Birth Rates: He noted a significant drop in live births following vaccination that suggests a potential link between vaccination and reproductive health issues.

General Issues with Reporting Systems (From the November 2023 NCI Report)

• Healthcare Provider Reluctance: Many testimonies, including those from Dr. Gregory Chan and Dr. Charles Hoffe, indicated that healthcare providers faced obstacles in reporting adverse events. These included technical difficulties with reporting systems, lack of response from public health authorities, and fear of professional repercussions.

• Patient Reports Dismissed: Patients’ adverse reactions were often dismissed by healthcare providers. For instance, Nurse Angela Taylor experienced a severe reaction that was not reported, and Kristin Ditzel’s adverse reaction was not acknowledged as being related to the vaccine.

Corroborating Evidence from the 2023 NCI Report

The 2023 NCI Report provides detailed evidence supporting these testimonies:

Underreporting and System Failures

• Fatal Flaws in Reporting Systems: The 2023 Report highlighted the flaws in the adverse event reporting systems, particularly their reliance on healthcare professionals to report events. Many healthcare workers were discouraged from reporting, and some faced professional risks for doing so.

• Broken Monitoring System: The 2023 NCI Report described a “broken, impossible to use system,“ where accurate and timely reporting of adverse events was hindered by gatekeepers and administrative obstacles.

Data Analysis and Early Detection

• Importance of Robust Systems: The 2023 Report emphasized the need for comprehensive and user-friendly reporting systems to detect and respond to all potential side effects, especially for novel vaccines using unprecedented technology.

• Lack of Mid- and Long-Term Testing: It was noted that no mid-term or long-term testing was conducted prior to the approval of COVID-19 vaccines, which makes post-market surveillance critical for identifying adverse effects that were not evident in initial trials.

Public Trust and Data Transparency

• Building Public Trust: Transparent and effective monitoring of vaccine adverse reactions is crucial for maintaining public trust. The 2023 NCI Report stressed that the lack of transparency and the dismissal of adverse events contributed to growing public distrust in the vaccination program.

Recommendations

The Regina testimonies and the 2023 NCI Report collectively underscore the need for significant improvements in the adverse event reporting systems:

1. Immediately Discontinuing Use of mRNA vaccines.

2. Enhance Healthcare Provider Education: Educate and encourage healthcare providers to report adverse events without fear of reprisal.

3. Improve Reporting Systems: Make reporting systems more accessible and user-friendly for both healthcare providers and patients.

4. Increase Transparency: Ensure transparent communication about the risks of vaccines, including the acknowledgment and investigation of adverse events.

5. Conduct Comprehensive Studies: Perform mid-term and long-term studies on vaccine safety to better understand the potential risks associated with all vaccines.

6. Promote Public Engagement: Engage the public in reporting adverse events and educate them about the importance of reporting.

These steps are essential to address the gaps identified in the Regina testimonies and the 2023 NCI Report and to ensure a robust system for monitoring vaccine side effects and protecting public health.